FDA Issues Warning About Compounded Versions of Wegovy, Ozempic

WEDNESDAY, May 31, 2023 – Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they’re getting the medication, the U.S. Food and Drug Administration warned Tuesday. Shortages of the drug, commonly sold as...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news